21-1495: TRIS PHARMA, INC. v. ACTAVIS LABORATORIES FL, INC. [OPINION], NonprecedentialBy: Federal Circuiton July 7, 2022 at 1:10 pm Publication: U.S. Court of Appeals for the Federal CircuitLicensing, Litigation & Appeals Insights Downloadable Copy of Opinion>> Read More>>ShareTweetPinShare